Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1
about
DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growthThe roles of nitric oxide synthase and eIF2alpha kinases in regulation of cell cycle upon UVB-irradiationThreshold effects of nitric oxide-induced toxicity and cellular responses in wild-type and p53-null human lymphoblastoid cellscGMP-independent nitric oxide signaling and regulation of the cell cycle.Caspase-8-mediated BID cleavage and release of mitochondrial cytochrome c during Nomega-hydroxy-L-arginine-induced apoptosis in MDA-MB-468 cells. Antagonistic effects of L-ornithineRegulation of heme oxygenase-1 mRNA deadenylation and turnover in NIH3T3 cells by nitrosative or alkylation stressNitrosothiol signaling and protein nitrosation in cell deathAcoustophoretic synchronization of mammalian cells in microchannels.Nitric oxide induces cell death by regulating anti-apoptotic BCL-2 family members.Signaling pathways induced by a tumor-derived vaccine in antigen presenting cellsInhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer.Differential regulation of cyclin D1 expression by protein kinase C α and ϵ signaling in intestinal epithelial cells.Transcriptional regulation of SP-B gene expression by nitric oxide in H441 lung epithelial cellsCervical cancer cell supernatants induce a phenotypic switch from U937-derived macrophage-activated M1 state into M2-like suppressor phenotype with change in Toll-like receptor profile.Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide.Proteomic identification of mitochondrial targets of arginase in human breast cancer.On nitric oxide signaling, metamorphosis, and the evolution of biphasic life cycles.Increased susceptibility of breast cancer cells to stress mediated inhibition of protein synthesis.NO to breast: when, why and why not?Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Prostate carcinogenesis and inflammation: emerging insights.Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis.Differential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale.PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth.Mitochondrial nitric oxide in the signaling of cell integrated responses.Skeletal muscle function during exercise-fine-tuning of diverse subsystems by nitric oxideStaphylococcal entertotoxins of the enterotoxin gene cluster (egcSEs) induce nitrous oxide- and cytokine dependent tumor cell apoptosis in a broad panel of human tumor cells.Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment.Nitric oxide: a regulator of eukaryotic initiation factor 2 kinasesMitochondrial regulation of cell cycle and proliferation.The yin and yang of nitric oxide in cancer progression.iNOS: a potential therapeutic target for malignant glioma.A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms.Arsenic trioxide prevents nitric oxide production in lipopolysaccharide -stimulated RAW 264.7 by inhibiting a TRIF-dependent pathway.Nitric oxide donor-based platinum complexes as potential anticancer agents.Nitric oxide radical-induced radioadaptation and radiosensitization are G2/M phase-dependent.
P2860
Q24303568-ABEB0542-88A9-4081-B11F-BED2152CBAB3Q24632308-52C53794-F8CE-46FB-96AC-ACD73B972A16Q24649835-74D13ADC-88D8-44C7-87F6-92A915177D06Q24811327-35F4A7BA-622C-4AF4-8729-41AB1B5382E7Q28216199-3B9E88EC-6FD1-4970-A61D-BE855A9D6298Q28383512-AE2AE31B-380D-4142-A177-9EB4F06D2033Q28383796-FB36B825-2845-43D7-81FD-665EE6B8C0B2Q30475986-D651B2FF-1FC1-4A58-A4A6-1F01316E59FEQ33505312-3A2058B1-F054-415E-853A-88F27C012E10Q33895525-0A6C02B7-8791-4AB0-93B5-7203C47B000AQ33947770-C089A6B4-B01C-436E-9691-C048FA6F9549Q34070434-F02930D8-2ABD-4A77-8068-C7613B6DE0A0Q34085564-F5D9893D-DFBF-4325-8060-DF7B0C23790AQ34306761-4DD743A2-A6F6-41ED-9E62-E92B2B006E1EQ34558431-878987F7-8D63-4CD4-9643-4E593388F3E9Q34593813-F8AACFA6-8E6A-4E8A-8C60-A8B1AB726ECFQ34828944-44808E9E-F95C-4444-A533-C7D04E5DDCB6Q35041221-A46118D8-5FDA-45C5-ACD2-BE7CB8A826BFQ35209729-E73B9540-D4A6-4084-BB27-1A032637BCBCQ35560439-52E78766-1CC7-4185-97E5-5F96FFCF6A50Q35563549-9310DC9F-EB8D-4D1E-8330-7E81CE1A1ECFQ35799094-3354B313-6088-45E5-8842-BF7376FEFD6DQ35925066-06E8BC26-D8F3-4487-8C94-56ED3AA59812Q36090325-0AD4F84A-4983-41EF-BF23-AD248B398922Q36206691-49FA1606-76E6-4DCB-B983-E9F098BEC830Q36278234-59AFD686-B7FE-4C3D-B654-74B6DF643AE9Q36602038-BCF2A7B6-6BC2-445E-8886-A637AF9A9B54Q36818954-63ED8322-D3CE-43A4-BA02-877109249E1EQ36820423-4BCB290E-AF6C-4677-B4D4-F583ACA98E94Q37090032-48641575-ACA6-464E-8F58-5085DB48FDAEQ37718207-803E10FA-EA11-43D8-B860-C52AB4BDBD5BQ37861329-D2A2E406-0A58-49B6-9751-4E283CCA595AQ37941864-B029F342-6235-4DB7-8FA9-B97B283B7B31Q38077081-B39D1102-DF8C-4FD4-9C52-28B80A008F8BQ38099450-9B0196E9-C621-40B5-8D0D-2F918487F5FAQ38878220-4CD90706-2686-4821-B9D4-933794FAB3A0Q38981350-0AD00054-2EFB-4678-AD2D-5F3F8194E26FQ39252319-8EFA5DF9-7F91-4191-8C2C-0F9F53523646Q39270724-859607DE-C73A-4338-A56D-CBE2A29A195FQ39506497-A7B91555-C04A-4560-8A52-AF1EFFC875C3
P2860
Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Nitric oxide-induced cytostasi ...... ): potential role of cyclin D1
@ast
Nitric oxide-induced cytostasi ...... ): potential role of cyclin D1
@en
Nitric oxide-induced cytostasi ...... ): potential role of cyclin D1
@nl
type
label
Nitric oxide-induced cytostasi ...... ): potential role of cyclin D1
@ast
Nitric oxide-induced cytostasi ...... ): potential role of cyclin D1
@en
Nitric oxide-induced cytostasi ...... ): potential role of cyclin D1
@nl
prefLabel
Nitric oxide-induced cytostasi ...... ): potential role of cyclin D1
@ast
Nitric oxide-induced cytostasi ...... ): potential role of cyclin D1
@en
Nitric oxide-induced cytostasi ...... ): potential role of cyclin D1
@nl
P2093
P2860
P3181
P356
P1476
Nitric oxide-induced cytostasi ...... ): potential role of cyclin D1
@en
P2093
P2860
P304
P3181
P356
10.1073/PNAS.041603998
P407
P577
2001-03-13T00:00:00Z